• Protease inhibitors that have been developed and are currently used in clinical practice include: Antiretroviral HIV-1 protease inhibitors—class stem...
    15 KB (1,168 words) - 04:21, 24 December 2023
  • ligands, like protease inhibitors, that can modulate catalytic activities has an enormous therapeutic effect. Hence, inhibition of the HIV protease is one of...
    33 KB (4,117 words) - 22:23, 23 August 2022
  • Thumbnail for HIV-1 protease
    active protease cannot mature into infectious virions. Several protease inhibitors have been licensed for HIV therapy. There are ten HIV-1 PR inhibitors that...
    20 KB (2,197 words) - 00:57, 13 January 2024
  • produced in the presence of protease inhibitors are defective and mostly non-infectious. Examples of HIV protease inhibitors are lopinavir, indinavir, nelfinavir...
    134 KB (15,824 words) - 14:29, 11 April 2024
  • Thumbnail for Ritonavir
    Ritonavir (category HIV protease inhibitors)
    medications to treat HIV/AIDS. This combination treatment is known as highly active antiretroviral therapy (HAART). Ritonavir is a protease inhibitor, though it...
    41 KB (3,407 words) - 13:51, 21 January 2024
  • Thumbnail for Active site
    inhibitors and cannot function anymore. HIV protease inhibitors are used to treat patients having AIDS virus by preventing its DNA replication. HIV protease...
    40 KB (4,839 words) - 23:49, 6 November 2023
  • Thumbnail for Nelfinavir
    Nelfinavir (category HIV protease inhibitors)
    medication used in the treatment of HIV/AIDS. Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is almost...
    15 KB (1,435 words) - 18:46, 17 March 2024
  • Thumbnail for Lopinavir/ritonavir
    Lopinavir/ritonavir (category HIV protease inhibitors)
    used in pregnancy and it appears to be safe. Both medications are HIV protease inhibitors. Ritonavir functions by slowing down the breakdown of lopinavir...
    19 KB (1,540 words) - 19:28, 20 December 2023
  • Thumbnail for Indinavir
    Indinavir (category HIV protease inhibitors)
    Crixivan, made by Merck) is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV/AIDS. It is soluble white powder...
    19 KB (2,292 words) - 07:16, 14 March 2024
  • Thumbnail for Atazanavir
    Atazanavir (category HIV protease inhibitors)
    Y, Wang Y (2015). "HIV protease inhibitors: a review of molecular selectivity and toxicity". HIV/AIDS. 7: 95–104. doi:10.2147/HIV.S79956. PMC 4396582...
    13 KB (1,025 words) - 04:40, 3 April 2024
  • Thumbnail for Saquinavir
    Saquinavir (category HIV protease inhibitors)
    appears to be safe in pregnancy. It is in the protease inhibitor class and works by blocking the HIV protease. Saquinavir was patented in 1988 and first...
    16 KB (1,116 words) - 19:41, 20 December 2023
  • Thumbnail for Darunavir
    Darunavir (category HIV protease inhibitors)
    on the HIV-1 protease structure. The HIV genome has high plasticity, so has been able to become resistant to multiple HIV-1 protease inhibitors. Since...
    21 KB (1,763 words) - 23:08, 30 March 2024
  • Thumbnail for Lopinavir
    Lopinavir (category HIV protease inhibitors)
    antiretroviral of the protease inhibitor class. It is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir (lopinavir/ritonavir)...
    9 KB (699 words) - 08:13, 19 February 2024
  • Thumbnail for Enzyme inhibitor
    treating rheumatic arthritis) and the protease inhibitors used to treat HIV/AIDS. Since anti-pathogen inhibitors generally target only one enzyme, such...
    104 KB (11,575 words) - 10:05, 2 March 2024
  • transition state analog inhibitors include flu medications such as the neuraminidase inhibitor oseltamivir and the HIV protease inhibitors saquinavir in the...
    12 KB (1,363 words) - 03:36, 27 October 2023
  • Thumbnail for Protease
    therapeutic agents. Other natural protease inhibitors are used as defense mechanisms. Common examples are the trypsin inhibitors found in the seeds of some plants...
    26 KB (2,799 words) - 22:42, 25 April 2024
  • Thumbnail for Amprenavir
    Amprenavir (category HIV protease inhibitors)
    produce the HIV peptide coat. Structure–activity studies on renin inhibitors proved to be of great value for developing HIV protease inhibitors. Incorporation...
    5 KB (319 words) - 13:19, 19 December 2023
  • Thumbnail for Tipranavir
    Tipranavir (category HIV protease inhibitors)
    treat HIV infection.[citation needed] Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and...
    5 KB (317 words) - 18:50, 30 November 2023
  • Thumbnail for Elvitegravir
    Elvitegravir (category Integrase inhibitors)
    strong UGT1A inhibitors such as ritonavir and other HIV protease inhibitors. (But ritonavir also increases elvitegravir levels by inhibiting CYP3A.) Furthermore...
    10 KB (849 words) - 11:30, 7 November 2023
  • (HIV protease inhibitor) Darunavir (HIV protease inhibitor) Delavirdine (non-nucleoside reverse transcriptase inhibitor) Fosamprenavir (HIV protease inhibitor)...
    4 KB (260 words) - 08:48, 25 November 2023
  • Thumbnail for HIV
    Discovery and development of HIV-protease inhibitors HIV/AIDS denialism World AIDS Day Weiss RA (May 1993). "How does HIV cause AIDS?". Science. 260 (5112):...
    125 KB (14,342 words) - 15:53, 2 May 2024
  • Thumbnail for Fosamprenavir
    Fosamprenavir (category HIV protease inhibitors)
    Lexiva and Telzir, is a medication used to treat HIV/AIDS. It is a prodrug of the protease inhibitor and antiretroviral drug amprenavir. It is marketed...
    9 KB (552 words) - 05:04, 22 January 2024
  • Thumbnail for PDE5 inhibitor
    adverse drug interactions with other drugs which inhibit or induce CYP3A4, including HIV protease inhibitors, ketoconazole, and itraconazole, although coadministration...
    16 KB (1,721 words) - 14:51, 11 March 2024
  • Thumbnail for HIV/AIDS research
    Discovery and development of HIV-protease inhibitors Discovery and development of non-nucleoside reverse-transcriptase inhibitors Discovery and development...
    41 KB (5,105 words) - 19:34, 20 April 2024
  • Thumbnail for HIV/AIDS
    transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase, inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs)...
    204 KB (20,934 words) - 16:06, 4 May 2024
  • used to treat HIV-associated lipodystrophy.[citation needed] Reversion of lipodystrophy does not occur after withdrawal of protease inhibitors. Drug-induced...
    4 KB (352 words) - 22:11, 28 January 2023
  • Thumbnail for Brecanavir
    Brecanavir (category HIV protease inhibitors)
    Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV. In December 2006, its developer, GlaxoSmithKline...
    4 KB (126 words) - 13:33, 19 December 2023
  • Thumbnail for Ice-nine
    Almarsson O (March 2003). "Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization". Proc. Natl. Acad...
    9 KB (1,168 words) - 23:24, 29 April 2024
  • Thumbnail for HIV/AIDS in Europe
    therapy, deaths from AIDS have stayed low since the introduction of protease inhibitors and combination therapy in the late 1990s. 14% are believed to have...
    31 KB (3,771 words) - 00:56, 29 April 2024
  • Reverse-transcriptase inhibitors (RTIs) are a class of antiretroviral drugs used to treat HIV infection or AIDS, and in some cases hepatitis B. RTIs inhibit activity...
    25 KB (2,906 words) - 07:02, 4 April 2024